A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1994
11/24/1994	CA2160786A1 Ras farnesyl transferase inhibitors
11/24/1994	CA2160458A1 Cho cell sialidase by recombinant dna technology
11/24/1994	CA2159728A1 Synthetic aglucodalbaheptide antibiotics
11/24/1994	CA2139651A1 Amylin antagonists and agonists
11/23/1994	EP0625580A1 Novel hirudine variant, process for producing the same, and anticoagulant containing the same as active ingredient
11/23/1994	EP0625354A1 Medical preparation containing the subunit p40 of interleukin 12
11/23/1994	EP0625202A1 Serum-human albumin, preparation and utilization
11/23/1994	EP0625201A1 Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5
11/23/1994	EP0625199A1 Antithrombotic polypeptides as antagonists of the binding of vwf to platelets or to subendothelium
11/23/1994	EP0625198A1 EXPRESSION OF OSTEOGENIC FACTOR OP-1 IN CELLS OF $i(SPODOPTERA FRUGIPERDA) INFECTED WITH RECOMBINANT BACULOVIRUS
11/23/1994	EP0625196A1 Neurotrophic factor
11/23/1994	EP0625195A1 Therapy of central nervous system by genetically modified cells
11/23/1994	EP0625194A1 Enhancement of ribozyme catalytic activity by a neighboring facilitator oligonucleotide.
11/23/1994	EP0625192A1 Nucleozymes
11/23/1994	EP0625164A1 CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa
11/23/1994	EP0625163A1 Parathyroid hormone fragments, their preparation and medicaments containing the same
11/23/1994	EP0625162A1 Methods of producing analgesia and enhancing opiate analgesia
11/23/1994	EP0625161A1 Process for recovering a high-purity virus-inactivated factor viii by anion exchanger chromatography
11/23/1994	EP0625160A1 Leukinferon preparation
11/23/1994	EP0625159A1 Ikaros: a t cell pathway regulatory gene
11/23/1994	EP0625145A1 3-phenylureido-azepin-2-ones and -benzazepin-2-ones useful as cholecystokinin antagonists
11/23/1994	EP0625053A1 Urease-based vaccine against helicobacter infection
11/23/1994	EP0625051A1 Hepatic growth factor receptor
11/23/1994	EP0625049A1 Ex vivo gene transfer
11/23/1994	EP0625048A1 Synthesis of human procollagens and collagens in recombinant dna systems
11/23/1994	EP0625047A1 Platelet transfusion
11/23/1994	EP0535088A4 Chimeric toxins with improved inter-domain geometry
11/23/1994	EP0531461B1 Biologically active peptides containing d-2-alkyltryptophan
11/23/1994	EP0464101B1 Improvements relating to the radio-labelling of proteins
11/23/1994	CN1095268A Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
11/22/1994	US5367064 Proteins as enzyme inhibitors
11/22/1994	US5367063 Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis
11/22/1994	US5367060 Structure, production and use of heregulin
11/22/1994	US5367059 Cys-Ser-Val-Thr-Cys-Gly specific tumor cell adhesion receptor
11/22/1994	US5367056 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
11/22/1994	US5367053 Opioid peptide inhibitors
11/22/1994	US5367052 Amylin peptides
11/22/1994	US5366994 Enzyme inhibitors
11/22/1994	US5366977 Method of treating cystic fibrosis using 8-cyclopentyl-1,3-dipropylxanthine or xanthine amino congeners
11/22/1994	US5366973 Mercaptoacetylamido pyridazo [1,2]pyridazine, pyrazolo[1,2]pyridazine pyrazolo[1,2]pyridazine, pyridazol[1,2-a][1,2]diazepine and pyrazolol[1,2-a][1,2]diazepine
11/22/1994	US5366964 Viscoelastic solution
11/22/1994	US5366886 Human tissue plasminogen activator variant
11/22/1994	US5366875 Methods for producing BMP-7 proteins
11/22/1994	US5366736 Vitamin D derivative feed compositions and methods of use
11/22/1994	US5366730 Stabilized compositions having human tissue type plasminogen activator enzymatic activity
11/22/1994	US5366728 Vaccines for immunology of ruminants
11/22/1994	US5366440 Methods for treating disease states using oxidized lipoproteins in conjunction with chemotherapeutic effector agents
11/22/1994	CA1333151C Pharmaceutical compositions and use thereof in treating inflammation
11/22/1994	CA1333150C Method for the control of pneumocystis carinii
11/18/1994	CA2123921A1 Polypeptide compound and a process for preparation thereof
11/18/1994	CA2123523A1 Use of compositions for combating tumour diseases
11/17/1994	EP0624649A1 Polypeptide derived from a human glioblastoma cell line and DNA's encoding it
11/17/1994	EP0624648A1 Polypeptide derived form a human glioblastoma cell line and DNA's encoding it
11/17/1994	EP0624647A1 Polypeptide derived from a human gliobastoma cell line and DNAs encoding it
11/17/1994	EP0624646A1 Polypeptide derived from a human glioblastomer cell line and DNA's encoding it
11/17/1994	EP0624645A1 Human chondromodulin-I protein
11/17/1994	EP0624642A1 Novel thrombolytic agent, process for preparing same and its use for the preparation of a thrombi dissolving medicament
11/17/1994	EP0624598A1 Hepatitis B-binding factor
11/17/1994	EP0624402A2 Apparatus for uniformly applying a suspension on a collagen substrate
11/17/1994	EP0624377A2 Lysosomal enzyme-cleavable antitumor drug conjugates
11/17/1994	EP0624375A2 Pharmaceutical compositions containing hirudin
11/17/1994	EP0624368A2 Use of a composition for stimulating the synthesis of glutathione in the manufacture of a medicament for the treatment of acquired immune deficiency syndrome
11/17/1994	EP0624201A1 Method for producing soluble t-receptors by co-transfection, and use of resulting products
11/17/1994	EP0624200A1 New polypeptides having granulocyte colony stimulating activity, preparation thereof and pharmaceutical compositions containing said polypeptides
11/17/1994	EP0624199A1 Methods for producing thrombin
11/17/1994	EP0624198A1 Synthetic peptides for a rubella vaccine
11/17/1994	EP0624196A1 Polypeptides with fibronectin binding sites as modulators for matrix assembly.
11/17/1994	EP0624195A1 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides
11/17/1994	EP0624194A1 Polypeptides derived from human aiv apolipoprotein, preparation and use thereof
11/17/1994	EP0624193A1 Aamp-1, a protein with local homologies to hiv-1 env and nef proteins
11/17/1994	EP0624192A1 Novel protein tyrosine kinases
11/17/1994	EP0624164A1 Peptides with organo-protective activity, process for their preparation and their use in the therapy
11/17/1994	EP0624163A1 Cyclic calcitonin derivatives and method for their production
11/17/1994	EP0624100A1 Dna encoding a human serotonin receptor (5-ht 4b?) and uses thereof
11/17/1994	EP0624095A1 Methods and compositions for reducing blood loss
11/17/1994	EP0624094A1 Use of fibroblast growth factors as neuroprotective and neuromodulatory agents
11/17/1994	EP0624093A1 The use of a compound for the manufacture of a medicament for the treatment of hiv infection
11/17/1994	EP0624088A1 Amino acids useful as inhibitors of the advanced glycosylation of proteins
11/17/1994	EP0563280B1 Tissue plasminogen activator substitution variant
11/17/1994	EP0540676B1 Peptide compounds having growth hormone releasing activity
11/17/1994	EP0300033B1 Cytotoxic lymphocyte-specific protease-related molecules and methods
11/17/1994	EP0298990B1 Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive
11/17/1994	EP0109441B1 Human-human hybridomas for neoplasms
11/16/1994	CN1095106A Vaccines
11/16/1994	CN1095072A Difluoro pentapeptide derivative anti-inflammatory agents
11/16/1994	CN1094965A Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of b cell lymphoma
11/15/1994	US5364934 Plasma carboxypeptidase
11/15/1994	US5364933 Methods of immunopurification of antigens of human immunodeficiency virus type 2 (HIV-2)
11/15/1994	US5364932 Pasteurizable, freeze-driable hemoglobin-based blood substitute
11/15/1994	US5364931 Phosphonate-containing pseudopeptides of the hydroxyethylamine and norstatin type
11/15/1994	US5364930 Synthetic C1q peptide fragments
11/15/1994	US5364842 Method of producing analgesia
11/15/1994	US5364841 Treatment of obesity and essential hypertension and related disorders
11/15/1994	US5364840 Synthetic calcitonin peptides
11/15/1994	US5364839 Osteoinductive pharmaceutical formulations
11/15/1994	US5364838 Method of administration of insulin
11/15/1994	US5364837 Follicle stimulating hormone for producing antibodies
11/15/1994	US5364791 Progesterone receptor having C. terminal hormone binding domain truncations
11/15/1994	US5364771 Genetic engineering
11/15/1994	US5364769 Nucleic acid encoding neurotrophic factor four (NT-4), vectors, host cells and methods of production

1 ... 2870 2871 2872 2873 2874 2875 2876 2877 2878 2879 2880 2881 2882 2883 2884 2885 2886 2887 2888 2889 2890 ... 3163